I cant see China approving of RAP easily considering it is a smartphone application. They will have their concerns about cyber security. But this announcement is great news today and brings the risk profile down a little
Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark, page-32
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #